PGY-2 Infectious Diseases

This residency is a 12-month ASHP-accredited postgraduate program that builds upon the experiences in a PGY-1 residency with a focus in infectious diseases. The PGY2 Infectious Diseases residency at UMMC was developed in 1991 under the leadership of Dr. John Cleary, and we have a long history of successful residents. 

The resident will maintain an active practice in the Division of Infectious Diseases, Department of Antimicrobial Stewardship, and Department of Pharmacy. Patient care services will be provided for both inpatient and outpatient clients to ensure continuity of care.

Primary practice sites include:

University of Mississippi Medical Center: UMMC is a 722-bed tertiary care hospital near downtown Jackson and serving the entire state of Mississippi as the largest diagnostic, treatment and referral care system in the state. UMMC offers the only Level 1 trauma center, the only Level 4 neonatal intensive care nursery, and the only organ transplant programs in the state, in addition to Children's of Mississippi, Mississippi's only hospital solely dedicated to caring for children. The UMMC microbiology laboratory is staffed by medical technologists and clinical laboratory scientists 24 hours a day, seven days a week.

Rotations may include, but are not limited to:

*Month-long unless denoted as “longitudinal”

**Any rotation available at UMMC for the PGY1 residents may be arranged for the PGY2 resident, pending availability.

***The Community Antimicrobial Stewardship rotation occurs at St. Dominic-Jackson Memorial Hospital. St. Dominic is a 571-bed acute care facility in Jackson, serving a variety of patient populations.

University of Mississippi School of Pharmacy: The Department of Pharmacy Practice administers approximately 60 percent of the professional pharmacy curriculum, including the Professional Experience Program. Pharmacy practice faculty direct courses in all years of the curriculum. Teaching opportunities for the resident may include (but are not limited to):

• providing infectious diseases-related lectures or active-learning sessions during the P2 or P3 modules
• helping with the infectious diseases elective during the P3 year
• facilitating active-learning sessions in the multisystem complex patient cases course during the P3 year
• facilitating interprofessional education sessions or skills labs
• precepting students on introductory and advanced pharmacy practice experiences

Role of the PGY2 Infectious Diseases Resident

Program Purpose

In addition to the ASHP Goals and Objectives, the purpose of the PGY2 residency program at UMMC is:

• To develop confident and competent infectious diseases practitioners.
• To promote a desire for pursuit and participation in infectious diseases research.
• To develop well-rounded educators effective in teaching current health care professionals and health care professionals in training. 

Educational Opportunities

Over the course of the program, the resident is responsible for longitudinal clinical practice and administrative work in infectious diseases and antimicrobial stewardship and monthly rotations in a variety of areas. The resident will participate in “Bugs and Drugs” sessions with the preceptors and/or ID Division, monthly journal club and pharmacy grand rounds with other pharmacy residents, and multiple other learning opportunities including weekly ID conference, medicine grand rounds, and continuing education seminars.

Example Rotation Schedule:

Research and Scholarship

The resident will serve as the primary investigator/lead researcher and be responsible for the design and completion of one major research project and one scholarly endeavor. The scholarly endeavor will be determined based on interest, and options may include (but are not limited to) quality improvement projects, review articles, pharmacokinetic/pharmacodynamic studies, outcomes studies, and case series.  

Examples of previous resident research and scholarship:

• Keck JM, et al. Approach to fever in patients with neutropenia: a review of diagnosis and management. Ther Adv Infect Dis. 2022;9:20499361221138346. 
• Markovich K, et al. Analysis of the clinical impact of the BioFire FilmArray Meningitis Encephalitis Panel on antimicrobial use and duration of therapy at an academic medical center. Diseases. 2022 Nov 20;10(4):110. 
• Hawkins BK et al. An evaluation of antipseudomonal dosing on the incidence of treatment failure. SAGE Open Med. 2021;9:20503121211000927.   
• Gunter SG et al. Fluoroquinolone versus nonfluoroquinolone treatment of bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Antibiotics (Basel). 2020;9(6):331.
• Wingler MJB et al. An evaluation of pharmacist-led interventions for inpatient HIV-related medication errors. J Pharm Technol. 2019.
• Barber KE et al. Omadacycline enters the ring: a new antimicrobial contender. Pharmacotherapy. 2018;38(12):1194-1204.
• Chastain DB et al. Rethinking urinary antibiotic breakpoints: analysis of urinary antibiotic concentrations to treat multidrug resistant organisms. BMC Res Notes. 2018;11(1):497.
• White BP et al. Risk factors for failure in complicated intraabdominal infections. South Med J. 2018;111(2):125-32.
• Rac H et al. Impact of an antifungal stewardship intervention on optimization of candidemia management. Ther Adv Infect Dis. 2018;5(1):3-10.
• Rac H et al. Time-kill analysis of ceftolozane/tazobactam efficacy against mucoid Pseudomonas aeruginosa strains from cystic fibrosis patients. Infect Dis Ther. 2017;6(4):507-513.
• White BP et al. Mechanisms of fosfomycin resistance in carbapenem-resistant Enterobacter sp. Int J Antimicrob Agents. 2017;50(5):690-2.
• Cretella D et al. Comparison of susceptibility patterns using commercially available susceptibility testing methods performed on prevalent Candida spp. J Med Microbiol. 2016;65(12):1445-51.
• Chastain DB et al. Epidemiology and management of antiretroviral-associated cardiovascular disease. Open AIDS J. 2015;9:29-38.
• Otting KA. Drug-laboratory interaction between beta-lactam antibiotics and the galactomannan antigen test used to detect mould infections. Braz J Infect Dis. 2014;18(5):544-7.

Teaching Opportunities

The resident will develop teaching skills related to experiential and didactic learning. The resident will have the opportunity to precept pharmacy students and residents in infectious diseases and antimicrobial stewardship, prepare and deliver didactic lectures and active-learning activities, and will have the opportunity to complete a Teaching and Learning Certificate through the School of Pharmacy if desired.

2023 Recruitment (Residency Year 2024-2025)

• We will be participating in ASHP's Personal Placement Service (PPS) at Midyear 

Please contact Kayla Stover (kstover@umc.edu) for more information about the program or to set up a one-on-one meeting to discuss further prior to the application deadline.